Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2010-09-10FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Mylan Pharmaceuticals Inc., resulting in a labeling update.
-
FDA approval · 2010-09-07FDA Approved: LITHIUM CARBONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's supplemental application for a generic lithium carbonate product, updating its approval status. The action does not …
-
FDA approval · 2010-09-03FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for SAPHRIS (asenapine maleate) by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania [Phase 4]
Phase 4 clinical trial evaluating donepezil as an adjunct to mood stabilizers for acute mania in bipolar disorder; the study has completed.
-
FDA approval · 2010-08-30FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-TAB (risperidone) from Janssen Pharmaceuticals, expanding or updating its formulatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-25Clinical Trial Update: Tryptophan Depletion in Acute Mania [NA]
A completed clinical trial evaluated tryptophan depletion in individuals with bipolar disorder experiencing acute mania.
-
CLINICAL_TRIALS research · 2010-08-25Clinical Trial Update: Bipolar Disorder With Alcoholism in Han Chinese
An update on a clinical trial investigating bipolar disorder with alcoholism in Han Chinese, sponsored by National Cheng-Kung University Hos…
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Riluzole in the Treatment of Bipolar Depression [NA]
Clinical trial update on riluzole for bipolar depression; status completed with results posted.
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Reduction of Cardiovascular Risk in Severe Mental Illness [Phase 4]
Phase 4 clinical trial update exploring reduction of cardiovascular risk in individuals with severe mental illness, including schizophrenia …
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness [Phase 4]
A Phase 4 clinical trial update reports on the 24-week effectiveness of Abilify (aripiprazole) for bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness [NA]
Clinical trial update noting the completion and outcome evaluation of the Solutions for Wellness and Team Solutions Program in adults with s…
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical's generic risperidone (ANDA) for the same indications as the brand-label. The approval covers schizophrenia,…
-
FDA approval · 2010-08-06FDA Approved: RISPERIDONE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original ANDA for risperidone, providing a generic version of this antipsychotic.
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc., indicating regulatory action on the lamotrigine …
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Glenmark's generic lamotrigine product. The approval confirms the generic's labeling and regulat…
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: An Evaluation Of BW430C (Lamotrigine) Versus Placebo In The Prevention Of Mood Episodes In Bipolar I Disorder Patients [Phase 3]
Phase 3 trial evaluating BW430C (lamotrigine) versus placebo for prevention of mood episodes in bipolar I disorder has completed. Results we…
-
CLINICAL_TRIALS trial_result · 2010-07-23Clinical Trial Update: Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
An update on a clinical trial evaluating the efficacy and safety of psychopharmacotherapy in patients with schizophrenia or bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2010-07-16Clinical Trial Update: 40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) [Phase 3]
Phase 3 40-week extension study of asenapine and olanzapine for bipolar disorder has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating ramelteon for insomnia and mood stability in euthymic bipolar disorder has completed with results posted.
-
FDA approval · 2010-06-29FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone, updating the labeling for this generic product.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder [Phase 3]
Phase 3 results evaluate the efficacy and safety of extended olanzapine treatment for manic or mixed episodes in bipolar I disorder.
-
CLINICAL_TRIALS trial_result · 2010-06-25Clinical Trial Update: Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness [Phase 4]
Phase 4 clinical trial update assessing the 6-week effectiveness of Abilify (aripiprazole) for bipolar disorder. The study, conducted by Kor…
-
FDA approval · 2010-06-24FDA Approved: LITHIUM CARBONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original application for lithium carbonate from Sun Pharmaceutical Industries, expanding access to this generic medicine.
-
FDA approval · 2010-06-23FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc., granting approval for changes to the alread…